Last reviewed · How we verify
Long Term Multiple Dose, Open-Label, Multi-Center Study to Evaluate the Safety and Tolerability of OXC XR as Adjunctive Therapy in Pediatric Subjects With Refractory Partial Epilepsy
Follow-on study to continue evaluation of the safety of OXC XR as adjunctive therapy in pediatric epilepsy
Details
| Lead sponsor | Supernus Pharmaceuticals, Inc. |
|---|---|
| Status | APPROVED_FOR_MARKETING |
| Start date | 2009-06 |
Conditions
- Epilepsy
Interventions
- Oxcarbazepine Extended Release
Countries
United States